Jessilin Quint, OD, MBA, MS, FAAO

The survey’s results were released by Bausch + Lomb last month and revealed that many participants did not know their symptoms were dry eye-related.

Focusing on the care of patients with MGD, Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO, provide key takeaways on treatment practices.

Dry eye experts provide comprehensive insights on the role of in-office procedural therapies.

Selina McGee, OD, FAAO, discusses the role of cyclosporine ophthalmic solution (VEVYE) in the treatment of dry eye disease.

Experts provide clinical insights on the first FDA-approved treatment for evaporative dry eye, perfluorohexyloctane ophthalmic solution (MEIBO).

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO, discuss the first-line treatment of MGD, highlighting factors that inform treatment selection.

Experts on dry eye describe the potential long-term consequences for patients if MGD is left untreated.

Dry eye specialists provide detailed insights on the differences between aqueous-deficient and evaporative dry eye disease.

Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO, provide an overview of meibomian gland dysfunction (MGD) and its causes.

Jessilin Quint, OD, MBA, MS, FAAO, shares the latest and greatest in the world of dry eye, from new technology to how clinicians can start in on dry eye therapy today.

These 8 pearls will help improve your patient care, practice management, and more.

Water gradient tech, high-tech materials, and new therapies offer more options.

Help presbyopia patients by following fitting guides and embracing new adjunct therapy options.